Close Menu

NEW YORK, July 11 (GenomeWeb News) - An investment bank this morning downgraded Affymetrix stock, forcing shares in the microarray marker leader to slide 4.9 percent, or $2.92, to $56.33 by late afternoon.


To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.